IL-8, IL-6 and ICAM-1 in serum of paediatric patients undergoing cardiopulmonary bypass with and without cardiocirculatory arrest

Journal of Cardiovascular Surgery

Volumn 40, Issue 6, 1999, Pages 803-809

  Antonelli, M ^a   Testa, G ^b   Tritapepe, L ^a   D'Errico, R R ^a   Costa, D ^b   Giovannelli, L ^c   Riccioni, L ^a   Gasparetto, A ^a   Catena, G ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Med Surg Dept of Pediat Cardiol   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Cardiopulmonary bypass; Child; Cytokines; Heart arrest; Induced

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8;

ARTICLE; BLOOD ANALYSIS; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; HEART ARREST; HEART MUSCLE REPERFUSION; HUMAN; INFANT; INFLAMMATION; NEWBORN; OPERATION DURATION; POSTOPERATIVE PERIOD;

CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0033383474     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med 1987;13:89-95.
2. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-incluced multisystem organ failure. Ann Thorac Surg 1993;56s:92-6.
3. Finn A, Rebuck N, Strobel S, Moat N, Elliot M. Systemic inflammation during paediatric cardiopulmonary bypass: changes in neutrophil adhesive properties. Perfusion 1993;8:39-48.
4. kirklin Jk, Blackstone Ek, kirklin JW, Mckey R, Pacifico AD, Bargeron LM. Intracardiac surgery in infants under age 3 months: incremental risk factors for hospital mortality. Am J Cardiol 1981;48:500-6.
5. Westaby S. Complement and damaging effects of cardiopulmonary bypass. Thorax 1983;38:321.
6. Finn A, Naik S, klein N, Levinsky RJ. Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after paediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
7. Cavarocchi NC, Pluth JR, Schaff HV, Orszulak TA, Solis E, kaye MP et al. Complement activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986;91:252-8.
8. kawamura T, Wakusawa R, Okada k, Inada S. Evaluation of cytokines during open heart surgery with cardiopulmonary bypass: participation of IL-8 and IL-6 in reperfusion injury. Can J Anaesth 1993;56s:92-6.
9. Jorens PG, De Jongh R, De Backer W, Van Damme J, Van Overveld F, Bossaert L et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass. Am Rev Respir Dis 1993;148:890-5.
10. Jensen NJG, van Oeveren, Wildevuur CRH, kazatchkine MD. Methylprednisolone inhibits granulocytopenia induced by infusion of complement-activated serum, but no complement-activated plasma in rabbits. Biomaterials 1989;10:617-21.
11. Bauer J, Herrmann F. Interleukin-6 in clinical medicine. Ann Hematol 1991;62:203-7.
12. Antonelli M, Raponi GM, Martino P, Rosa G, Conti G, Jalouk J et al. High IL-6 serum levels are associated with septic shock with severe leukopenia due to malignancies. Scand J Infect Dis 1995; 27:381-4.
13. Millar AB, Armstrong L, Van der Linder J, Moat N, Ekroth R, Westwick J et al. Cytokine production and haemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56: 1499-502.
14. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992;53:833-8.
15. Seghaye MC, Duchateau J, Grabitz RG, Nitsch G, Marcus C, Messmer BJ et al. Complement leukocyte elastase in full-term neonates undergoing cardiac operation. J Thorac Cardiovasc Surg 1994;108:29-36.
16. Hashimoto M, Shingu M, Ezaki I, Nobunaga M, Minamihara M, kato k et al. Production of soluble ICAM-1 from endothelial cells induced to IL1β and αTNF. Inflammation 1994;18(2):163-73.
17. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338(13):83-4.
18. kuster H, Degitz k. Circulating ICAM-1 in neonatal sepsis. Lancet 1993;341(20):506.
19. Rubin LA, kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchon R et al. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135:3172-7
20. Herynkopf F, Lucchese F, Pereira E, Kalil R, Prates Pnesralla I. Aprotinin in children undergoing correction of congenital heart defects. J Thorac Cardiovasc Surg 1994;108:517-21.
21. Gurevitch I, Barak J, Hochhauser E, Paz J, Yakirevich V. Aprotinin improves myocardial recovery after ischemia and reperfusion. J Thorac Cardiovasc Surg 1994;108:109-18.
22. Quiroga MM, Miyagishima R, Haendschen LC, Glovsky M, Martin BA, Hogg JC. The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985;90:91-6.